Welcome to our dedicated page for Inmode news (Ticker: INMD), a resource for investors and traders seeking the latest updates and insights on Inmode stock.
InMode Ltd. reports developments in medical-technology devices that use radiofrequency technology for minimally invasive and non-invasive aesthetic and medical procedures. Company updates commonly address product platforms and treatment categories for plastic surgery, dermatology, gynecology, otolaryngology and ophthalmology, including face and body contouring, medical aesthetics and women's health.
Recurring news also covers GAAP and non-GAAP financial results, consumables and service revenue, regional performance in the United States and Europe, margin trends, investor-conference participation, board-reviewed strategic matters and capital allocation actions such as ordinary-share repurchase programs.
InMode Ltd. (Nasdaq: INMD) announced Health Canada certification for its Evolve Tone device, marking it as Canada's first all-in-one hands-free body remodeling platform. This innovative technology encompasses three unique modalities: Tite, Trim, and Tone, catering to patient demands in skin remodeling, body contouring, and muscle strengthening. Dr. Michael Kreindel, Chief Technology Officer, emphasized its customization capabilities for diverse body types, while President Shakil Lakhani highlighted the strategic aim of expanding into the fast-growing Canadian aesthetic market.